The ROE as of December 2025 (TTM) for Yabao Pharmaceutical Group Co., Ltd (600351.SS) is 7.80%

According to Yabao Pharmaceutical Group Co., Ltd’s latest financial reports and current stock price. The company's current ROE is 7.80%. This represents a change of 301.61% compared to the average of 1.94% of the last 4 quarters.

Yabao Pharmaceutical Group Co., Ltd (600351.SS) Historical ROE (quarterly & annually)

How has 600351.SS ROE performed in the past?

The mean historical ROE of Yabao Pharmaceutical Group Co., Ltd over the last ten years is 5.50%. The current 7.80% ROE has changed 41.83% with respect to the historical average. Over the past ten years (40 quarters), 600351.SS's ROE was at its highest in in the March 2024 quarter at 3.85%. The ROE was at its lowest in in the December 2019 quarter at -7.91%.

Yabao Pharmaceutical Group Co., Ltd (600351.SS) ROE by Quarter and Year

Discovering the peaks and valleys of Yabao Pharmaceutical Group Co., Ltd ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Yabao Pharmaceutical Group Co., Ltd (600351.SS) Average ROE

How has 600351.SS ROE performed in the past?

The current ROE of Yabao Pharmaceutical Group Co., Ltd (600351.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Yabao Pharmaceutical Group Co., Ltd (600351.SS) ROE vs. Peers

How is 600351.SS’s ROE compared to its peers?

Yabao Pharmaceutical Group Co., Ltd’s ROE is less than Tibet Weixinkang Medicine Co., Ltd. (15.13%), less than ZhuZhou QianJin Pharmaceutical Co.,Ltd (10.08%), less than Jinhe Biotechnology Co. Ltd. (5.45%), less than Hunan Fangsheng Pharmaceutical Co., Ltd. (17.90%), greater than Wuhan Hiteck Biological Pharma Co.,Ltd (-8.03%), less than LanZhou Foci Pharmaceutical Co.,Ltd. (3.27%), greater than Zhejiang Starry Pharmaceutical Co.,Ltd. (-1.11%), less than Tianjin Lisheng Pharmaceutical Co.,Ltd. (7.90%), less than HPGC Renmintongtai Pharmaceutical Corporation (4.05%), greater than Harbin Medisan Pharmaceutical Co., Ltd. (-9.30%),

Build a custom stock screener for Yabao Pharmaceutical Group Co., Ltd (600351.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Yabao Pharmaceutical Group Co., Ltd using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Yabao Pharmaceutical Group Co., Ltd (600351.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Yabao Pharmaceutical Group Co., Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.